Catalysts for Nexlizet
9 tracked
Jan 9, 2026
approval
NEXLIZET (BEMPEDOIC ACID) — FDA approval
(bempedoic acid + ezetimibe)
→
Nov 21, 2025
approval
NEXLIZET (BEMPEDOIC ACID) — FDA approval
(bempedoic acid + ezetimibe)
→
Jul 21, 2025
approval
NEXLIZET (BEMPEDOIC ACID) — FDA approval
(bempedoic acid + ezetimibe)
→
Jul 21, 2025
approval
NEXLIZET (BEMPEDOIC ACID) — FDA approval
(bempedoic acid + ezetimibe)
→
Mar 22, 2024
approval
NEXLIZET (BEMPEDOIC ACID) — FDA approval
(bempedoic acid + ezetimibe)
→
Mar 22, 2024
approval
NEXLIZET (BEMPEDOIC ACID) — FDA approval
(bempedoic acid + ezetimibe)
→
Dec 13, 2023
approval
NEXLIZET (BEMPEDOIC ACID) — FDA approval
(bempedoic acid + ezetimibe)
→
Sep 20, 2023
approval
NEXLIZET (BEMPEDOIC ACID) — FDA approval
(bempedoic acid + ezetimibe)
→
Feb 26, 2020
approval
NEXLIZET (BEMPEDOIC ACID) — FDA approval
(bempedoic acid + ezetimibe)
→